Viatris (VTRS) | Stock Overview & Key Data

Viatris Inc. | Healthcare

$8.79

4.39%

| Compare Stocks:

Viatris vs Zoetis Viatris vs Haleon Plc - ADR Viatris vs Intra-Cellular Viatris vs United Therapeutics Viatris vs Neurocrine Viatris vs S&P 500 | Market

Viatris Performance Comparison

Loading chart data...

Viatris

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $8.42 High: $8.82

on May 15, 2025

52 Week Range

Low: $6.85 High: $13.55

on April 10, 2025

on November 25, 2024

All-Time High: $76.69 on April 20, 2015

Key Statistics

Market Cap i $10.4B

EPS i -0.53

P/E Ratio (TTM) i 235.80

Forward P/E i 3.27

P/B Ratio i 0.56

PEG Ratio i 3.27

Div. Yield i 5.46%

ROE i -3.24%

Beta i 0.885

Debt to Equity i 76.77

Financial Highlights

Profitability

Gross Margin i 35.68%

Operating Margin i 12.83%

Profit Margin i -4.30%

Returns and Earnings

Return on Assets (TTM) i 2.49%

Return on Equity (TTM) i -3.24%

EBITDA i $2.6B

Net Income (TTM) i $-634.2M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i $0.48

Estimated Dividend Yield i 5.46%

5 Year Average Dividend Yield i 0.89%

Last 12-Month Dividend Yield i 5.46%

Last 12-Month Dividend i $0.48

% of Earnings Paid as Dividends i 960.00%

Dividend Date i June 16, 2025

Ex-Dividend Date i May 23, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Viatris VTRS	10.36B Large-cap	-3.19%	17.65%	-18.97%	-31.41%	-29.15%	-19.85%	-25.42%	-43.73%
Zoetis ZTS	72.09B Large-cap	-0.83%	7.45%	2.47%	-8.45%	-1.40%	-7.89%	-1.37%	23.23%
Haleon Plc - ADR HLN	48.10B Large-cap	1.04%	5.53%	6.91%	13.74%	13.14%	22.91%	41.16%	41.16%
Intra-Cellular ITCI	14.05B Large-cap	0.14%	0.45%	56.54%	81.59%	56.54%	92.68%	104.13%	700.67%
United Therapeutics UTHR	14.02B Large-cap	-1.32%	6.71%	-18.48%	-16.33%	-15.63%	10.65%	61.14%	158.13%
Neurocrine NBIX	11.92B Large-cap	2.33%	25.06%	5.52%	2.40%	-12.77%	-15.50%	39.51%	-3.66%

Ownership & Short Interest

Insider Ownership i 0.53%

Institutional Ownership i 84.78%

Shares Short i 46M

Short Ratio i 2.75

Short % of Shares Outstanding i 4.38%

Average 10-Day Volume i 15M

Average 90-Day Volume i 14M

Viatris Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Viatris would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is VTRS's 52-week high and low?

In the last 52 weeks, Viatris reached a high of $13.55 (on November 25, 2024) and a low of $6.85 (on April 10, 2025).

What is the market cap and P/E ratio for VTRS?

Curious about Viatris's size and valuation? Its market capitalization stands at 10.36B. When it comes to valuation, the P/E ratio (trailing twelve months) is 235.80, and the forward P/E (looking ahead) is 3.27.

Does VTRS pay dividends? If so, what's the yield?

Yes, Viatris is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 5.46%, and the company is expected to pay out $0.48 per share over the coming year.

Who are Viatris's main competitors or similar companies to consider before investing?

When looking at Viatris, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	72.09B	Healthcare	Drug Manufacturers - Specialty & Generic	-7.89%	-1.37%
Haleon Plc - ADR HLN	48.10B	Healthcare	Drug Manufacturers - Specialty & Generic	22.91%	41.16%
Intra-Cellular ITCI	14.05B	Healthcare	Drug Manufacturers - Specialty & Generic	92.68%	104.13%
United Therapeutics UTHR	14.02B	Healthcare	Drug Manufacturers - Specialty & Generic	10.65%	61.14%
Neurocrine NBIX	11.92B	Healthcare	Drug Manufacturers - Specialty & Generic	-15.50%	39.51%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Viatris Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Viatris's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -3.24%, the Debt to Equity ratio from the most recent quarter is 76.77, and its Gross Profit Margin stands at 35.68%.

What is the recent revenue and earnings growth for VTRS?

Looking at Viatris's growth, its revenue over the trailing twelve months (TTM) was $15B. Compared to the same quarter last year (YoY), quarterly revenue grew by -8.10%, and quarterly earnings saw a YoY growth of -11.17%.

How much of VTRS stock is held by insiders and institutions?

Wondering who owns Viatris stock? Company insiders (like executives and directors) hold about 0.53% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 84.78%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.